Steward Partners Investment Advisory, LLC Qiagen N.V. Transaction History

Steward Partners Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $162,138 - $181,720	-3,580 Reduced 98.65%	49 $2,000
Q4 2022 Feb 15, 2023	SELL	$41.91 - $50.48 $631,374 - $760,481	-15,065 Reduced 80.59%	3,629 $181,000
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $49,693 - $61,260	1,215 Added 6.95%	18,694 $772,000
Q2 2022 Aug 04, 2022	BUY	$42.98 - $49.77 $748,109 - $866,296	17,406 Added 23843.84%	17,479 $825,000
Q1 2022 May 02, 2022	SELL	$42.23 - $54.3 $12,668 - $16,290	-300 Reduced 80.43%	73 $4,000

Q3 2021 Nov 12, 2021	BUY	$46.55 - $56.83 $13,965 - $17,049	300 Added 410.96%	373 $19,000
Q2 2021 Aug 13, 2021	SELL	$46.28 - $52.75 $1,157 - $1,318	-25 Reduced 25.51%	73 $4,000
Q4 2020 Feb 11, 2021	BUY	$46.09 - $54.74 $1,152 - $1,368	25 Added 34.25%	98 $5,000
Q2 2019 Jul 25, 2019	BUY	$35.73 - $41.39 $2,608 - $3,021	73 New	73 $2,000
Q4 2018 Jan 15, 2019	SELL	$32.65 - $37.95 $2,383 - $2,770	-73 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$31.23 - $37.47 $1,530 - $1,836	49 Added 204.17%	73 $3,000
Q1 2018 Apr 20, 2018	BUY	$31.01 - $34.72 $744 - $833	24 New	24 $0

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.